Controlling Microbial Growth in the Body: Antimicrobial Drugs

Introduction

This section covers the mechanisms, applications, and considerations of antimicrobial drugs, focusing on how these agents target and inhibit microbial growth within the human body. Understanding these principles is essential for effective treatment of infectious diseases and for minimizing the development of resistance.

Mechanisms of Antimicrobial Action

Drugs That Affect Bacterial Cell Walls

• Mechanism: These drugs disrupt the synthesis of peptidoglycan, an essential component of bacterial cell walls.

• Effect: Without a functional cell wall, bacteria become fragile and lyse due to osmotic pressure.

• Example: Penicillins and cephalosporins inhibit the enzymes that cross-link peptidoglycan strands.

• Note: These drugs are generally more effective against Gram-positive bacteria due to their thick peptidoglycan layer.

Drugs That Affect Protein Synthesis

• Mechanism: These drugs target bacterial ribosomes (70S), which differ from eukaryotic ribosomes (80S), allowing selective toxicity.

• Effect: Inhibition of protein synthesis prevents bacteria from producing essential proteins, leading to cell death or stasis.

• Example: Tetracyclines, aminoglycosides, and macrolides.

Drugs That Disrupt Cytoplasmic Membranes

• Mechanism: These drugs compromise membrane integrity, causing leakage of cellular contents.

• Effect: Disruption of the membrane leads to cell death.

• Example: Polymyxins (mainly for Gram-negative bacteria) and amphotericin B (for fungi).

Drugs That Inhibit Metabolic Pathways

• Mechanism: These drugs block key enzymatic reactions unique to microbes.

• Effect: Inhibition of metabolic pathways prevents bacteria from synthesizing essential molecules.

• Example: Sulfonamides inhibit folic acid synthesis in bacteria.

Drugs That Inhibit Nucleic Acid Synthesis

• Mechanism: These drugs interfere with DNA or RNA synthesis.

• Effect: Inhibition of nucleic acid synthesis prevents replication and transcription, leading to cell death.

• Example: Quinolones (e.g., ciprofloxacin) and rifampin.

Spectrum of Activity

• Broad-spectrum drugs: Effective against a wide range of microbes (both Gram-positive and Gram-negative).

• Narrow-spectrum drugs: Target a specific group of microbes, reducing the risk of disrupting normal flora.

Testing Antimicrobial Effectiveness

Diffusion Susceptibility Test (Kirby-Bauer Test)

• Bacteria are spread on an agar plate, and antibiotic-impregnated disks are placed on the surface.

• After incubation, zones of inhibition (clear areas) indicate effectiveness.

Minimum Inhibitory Concentration (MIC) Test

• Definition: The lowest concentration of an antimicrobial agent that inhibits visible growth of a microorganism.

• Methods: Broth dilution, E-test (plastic strip with gradient of antibiotic).

Minimum Bactericidal Concentration (MBC) Test

• Definition: The lowest concentration of an antimicrobial agent that kills 99.9% of the original inoculum.

• Determined by subculturing from MIC tubes onto antibiotic-free media.

Benefits and Drawbacks of Antimicrobial Use

• Benefits: Effective treatment of infections, reduced morbidity and mortality.

• Drawbacks: Disruption of normal microbiota, risk of superinfections, allergic reactions, and development of resistance.

Side Effects and Toxicity

• Some antimicrobials can cause toxicity to organs (e.g., nephrotoxicity, ototoxicity).

• Allergic reactions may occur in sensitive individuals.

Mechanisms of Antimicrobial Resistance

• Microbes may develop resistance through:

  • Enzymatic destruction or inactivation of the drug (e.g., beta-lactamases).

  • Alteration of drug targets (e.g., changes in ribosomal proteins).

  • Decreased permeability or increased efflux of the drug.

  • Bypassing the metabolic pathway targeted by the drug.

Prevention of Resistance

• Use antimicrobials only when necessary and as prescribed.

• Complete the full course of therapy to prevent survival of resistant strains.

• Combination therapy can reduce the likelihood of resistance development.

Clinical Considerations in Antimicrobial Therapy

• Consider the site of infection, patient history, and susceptibility of the pathogen.

• Monitor for adverse effects and adjust therapy as needed.

Summary Table: Mechanisms of Antimicrobial Action

Key Equations

• Therapeutic Index (TI):

• A higher TI indicates a safer drug.

Conclusion

Understanding the mechanisms, testing, and clinical considerations of antimicrobial drugs is crucial for effective infection control and for combating the rise of antimicrobial resistance.